Epstein-Barr DNA in advanced pediatric nasopharyngeal cancer

Epstein-Barr DNA in advanced pediatric nasopharyngeal cancer

Background Studies suggest that the most common type of nasopharyngeal carcinoma (NPC) is WHO-3, which is strongly associated with Epstein-Barr virus (EBV). Objective To assess NPC patient characteristics in a national general referral hospital in Indonesia, with regards to EBV DNA load and treat...

Full description

Bibliographic Details
Main Authors:	Marlinda Adham, Namira Kesuma Jelita, Djajadiman Gatot, Soehartati Argadikoesoema Gondhowiardjo, Lisnawati Rachmadi, Astrid E Greijer, I Bing Tan, Jaap M Middeldorp
Format:	Article
Language:	English
Published:	Indonesian Pediatric Society Publishing House 2021-09-01
Series:	Paediatrica Indonesiana
Subjects:	ebv pediatrics nasopharyngeal carcinoma asia indonesia
Online Access:	https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/2505

Similar Items

Molecular Detection of Epstein - Barr virus in Nasopharyngeal Carcinoma among Sudanese population
by: Ali Edris, et al.
Published: (2016-11-01)

Epstein-Barr Virus Mediated Signaling in Nasopharyngeal Carcinoma Carcinogenesis
by: Timmy Richardo, et al.
Published: (2020-08-01)

Novel Therapies Boosting T Cell Immunity in Epstein Barr Virus-Associated Nasopharyngeal Carcinoma
by: Sarah Renaud, et al.
Published: (2020-06-01)

Link of Nasopharyngeal Carcinoma and Epstein-Barr Virus
by: Sugiyanto Sugiyanto, et al.
Published: (2018-10-01)

Epstein–Barr Virus Gene BARF1 Expression is Regulated by the Epithelial Differentiation Factor ΔNp63α in Undifferentiated Nasopharyngeal Carcinoma
by: Eveline Hoebe, et al.
Published: (2018-03-01)

Analysis of Epstein Barr Virus Encoded RNA Expression in Nasopharyngeal Carcinoma in North-Eastern India: A Chromogenic in Situ Hybridization Based Study
by: Anjan Saikia, et al.
Published: (2016-05-01)

Plasma Epstein-Barr virus DNA and risk of nasopharyngeal carcinoma in a prospective seropositive population
by: Wen-Jie Chen, et al.
Published: (2021-06-01)

Lack of association between cigarette smoking and Epstein Barr virus reactivation in the nasopharynx in people with elevated EBV IgA antibody titres
by: Yufeng Chen, et al.
Published: (2018-02-01)

Prevalence of Epstein Barr Virus in biopsy specimens of nasopharyngeal carcinoma from Serbian patients
by: Banko Ana, et al.
Published: (2014-01-01)

Epstein–Barr Virus Infection of Pseudostratified Nasopharyngeal Epithelium Disrupts Epithelial Integrity
by: Fenggang Yu, et al.
Published: (2020-09-01)

Combining pretreatment plasma Epstein‐Barr virus DNA level and cervical node necrosis improves prognostic stratification in patients with nasopharyngeal carcinoma: A cohort study
by: Yu‐Yun Du, et al.
Published: (2019-11-01)

Expression of Epstein-Barr virus proteins and their detection by IgG antibodies
by: Rosek, Alyssa
Published: (2018)

Bilateral juvenile nasopharyngeal angiofibroma: A rare case report
by: Marlinda Adham, et al.
Published: (2021-01-01)

Maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography compared with Epstein-Barr virus DNA as prognostic indicators in de novo metastatic nasopharyngeal carcinoma patients
by: Xue-Song Sun, et al.
Published: (2019-09-01)

Epstein–Barr Virus LMP1 Induces Soluble PD-L1 in Nasopharyngeal Carcinoma
by: Kina Kase, et al.
Published: (2021-03-01)

A Systematic Review of Epstein–Barr Virus Latent Membrane Protein 1 (LMP1) Gene Variants in Nasopharyngeal Carcinoma
by: Ana Banko, et al.
Published: (2021-08-01)

Exosomal cyclophilin A as a novel noninvasive biomarker for Epstein‐Barr virus associated nasopharyngeal carcinoma
by: Lingzhi Liu, et al.
Published: (2019-06-01)

Clinical utility of Epstein‐Barr virus DNA and other liquid biopsy markers in nasopharyngeal carcinoma
by: Rong Tan, et al.
Published: (2020-11-01)

CRISPR/Cas9-mediated LMP1 knockout inhibits Epstein-Barr virus infection and nasopharyngeal carcinoma cell growth
by: Haifeng Huo, et al.
Published: (2019-10-01)

Air-Liquid Interface System To Understand Epstein-Barr Virus-Associated Nasopharyngeal Carcinoma
by: Sharon E. Hopcraft, et al.
Published: (2018-07-01)

Association Between Serum Cotinine Level and Serological Markers of Epstein–Barr Virus in Healthy Subjects in South China Where Nasopharyngeal Carcinoma Is Endemic
by: Qian-Yi Yang, et al.
Published: (2019-09-01)

Integrated Diagnostic Model That Incorporates Epstein-Barr Virus DNA, Imaging, and Nasal Endoscopy to Stratify Primary Tumor and Lymph Nodes in a Patient with N1 Nasopharyngeal Carcinoma: Multidisciplinary Management
by: Paolo Gamba, et al.
Published: (2018-05-01)

Human Leukocyte Antigens and Epstein-Barr Virus-Associated Nasopharyngeal Carcinoma: Old Associations Offer New Clues into the Role of Immunity in Infection-Associated Cancers
by: Wen-Hui eSu, et al.
Published: (2013-12-01)

Decreased oral Epstein‐Barr virus DNA loads in patients with nasopharyngeal carcinoma in Southern China: A case‐control and a family‐based study
by: Wen‐Qiong Xue, et al.
Published: (2018-07-01)

Generation and Characterization of a Novel Recombinant Antibody against LMP1-TES1 of Epstein-Barr Virus Isolated by Phage Display
by: Jin Zhu, et al.
Published: (2013-04-01)

Epstein Barr Virus related cancer in people living with HIV: a review of the literature
by: F. D’Andrea, et al.
Published: (2020-03-01)

The prognostic value of integration of pretreatment serum amyloid A (SAA)–EBV DNA (S-D) grade in patients with nasopharyngeal carcinoma
by: Jianpei Li, et al.
Published: (2020-01-01)

Role of Epstein-Barr virus in the development of nasopharyngeal carcinoma
by: Zhang Hui, et al.
Published: (2017-06-01)

Nasopharyngeal Carcinoma and Pulmonary Lymphoepithelioma-like Carcinoma – Metastases or Synchronous Second Primary Cancer
by: Ming-Kai Chuang, et al.
Published: (2015-09-01)

IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
by: Helen Heslop, et al.
Published: (2009-11-01)

IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
by: Alana Kennedy-Nasser, et al.
Published: (2009-11-01)

Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome
by: Lorenza Torti, et al.
Published: (2012-01-01)

Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma
by: Pok Man Hau, et al.
Published: (2020-05-01)

The Criteria to Confirm the Role of Epstein-Barr Virus in Nasopharyngeal Carcinoma Initiation
by: Ai-Di Gu, et al.
Published: (2012-10-01)

EBV‐LMP1 induces APOBEC3s and mitochondrial DNA hypermutation in nasopharyngeal cancer
by: Kousho Wakae, et al.
Published: (2020-10-01)

BZLF1 Expression of EBV is correlated with PARP1 Regulation on Nasopharyngeal Carcinoma Tissues
by: Wahyu nur laili fajri, Ahmad Rofi'i, Fatchiyah Fatchiyah
Published: (2013-04-01)

Chronic Active Epstein–Barr Virus Infection
by: Li Jun, et al.
Published: (2012-06-01)

Epstein-Barr Virus in Patients with Classical Hodgkin’s Lymphoma
by: VE Gurtsevitch, et al.
Published: (2018-04-01)

The Impact of Epstein-Barr Virus Infection on Epigenetic Regulation of Host Cell Gene Expression in Epithelial and Lymphocytic Malignancies
by: Merrin Man Long Leong, et al.
Published: (2021-02-01)

Current status of cancer care for young patients with nasopharyngeal carcinoma in Jakarta, Indonesia.
by: Marlinda Adham, et al.
Published: (2014-01-01)

Cannot write session to /tmp/vufind_sessions/sess_377sti6h5p4eore2n626t3bojm